GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Common Stock

e-Therapeutics (LSE:ETX) Common Stock : £0.58 Mil (As of Jul. 2023)


View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Common Stock?

e-Therapeutics's quarterly common stock increased from Jul. 2022 (£0.52 Mil) to Jan. 2023 (£0.58 Mil) and increased from Jan. 2023 (£0.58 Mil) to Jul. 2023 (£0.58 Mil).

e-Therapeutics's annual common stock increased from Jan. 2021 (£0.42 Mil) to Jan. 2022 (£0.52 Mil) and increased from Jan. 2022 (£0.52 Mil) to Jan. 2023 (£0.58 Mil).


e-Therapeutics Common Stock Historical Data

The historical data trend for e-Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Common Stock Chart

e-Therapeutics Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.27 0.42 0.52 0.58

e-Therapeutics Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.52 0.52 0.58 0.58

e-Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


e-Therapeutics (LSE:ETX) Business Description

Traded in Other Exchanges
Address
4 Kingdom Street, Paddington, London, GBR, W2 6BD
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines